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Cardiac paragangliomas are rare primary 
cardiac tumors arising from chromaffin cells of 
the sympathetic ganglia [1, 2]. Malignant para-
gangliomas are extremely uncommon, but they 
are associated with poor clinical outcomes due to 
high recurrence rates [3]. Complete surgical resec-
tion is considered the most effective treatment 
strategy with favorable long-term outcomes [4]. 
However, the optimal management of cardiac para-
gangliomas remains a challenging clinical dilemma 
owing to their high propensity for local invasion 
and proximity to major vascular structures that 
may preclude a curative surgical approach and 
affect long-term prognosis [3]. Preoperative as-
sessment is crucial to determine exact location, 
local extension, relationship with vascular struc-
tures and potential malignancy of cardiac masses. 
Noninvasive and invasive cardiac imaging remains 
therefore the mainstay of primary cardiac tumor 
assessment with the objective of achieving accu-
rate preoperative diagnosis and guide the optimal 
management strategy. Due to a lack of randomized 
clinical data, the appropriate preoperative manage-
ment of primary cardiac tumors remains however 
controversial. Echocardiography, cardiac computed 
tomography (CT), cardiac magnetic resonance 
(CMR) imaging, myocardial positron emission 
tomography (PET)-CT and coronary angiography 
separately provide complementary information, but 
the overall diagnostic accuracy is limited by their 
respective individual advantages and limitations. 
Comprehensive integration of advanced cardiac 
imaging modalities combining both morphological 
and functional information with the aim of guiding 
optimal management of rare but potentially fatal 
primary cardiac tumors has never been reported 
on to date.
Herein we report on a 43-year-old male with 
pituitary macroprolactinoma on long-term low-dose 
Cabergoline, an ergot-derived dopamine receptor 
agonist, who was referred to an outpatient car-
diology clinic for routine transthoracic echocar-
diogram (TTE) to rule-out drug-induced valvular 
heart disease. The TTE incidentally revealed 
a large 75 × 50 mm hyperechogenic paracardiac 
mass in direct contact with the basal lateral left 
ventricular (LV) wall and partially compressing the 
LV cavity without pericardial effusion. CMR imag-
ing (Fig. 1C, G, K) demonstrated a large, unique 
and well-circumscribed intrapericardial mass with 
fine granular appearance located at the level of the 
basal LV lateral wall and extending towards the 
atrioventricular groove. Gadolinium enhanced first 
pass perfusion imaging demonstrated intense and 
homogenous signal enhancement indicating dense 
vascularity. Late gadolinium enhancement imaging 
demonstrated bright and slightly inhomogeneous 
enhancement with a regularly enhanced outer 
rim, suggesting encapsulation. The mass appeared 
isointense to the myocardium on T1-weighted and 
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hyperintense on T2-weighted images suggesting 
high water content or slow flowing blood. Tagged 
cine CMR imaging showed normal deformation 
of the myocardium in direct contact to the mass 
during systole, excluding significant myocardial 
invasion. Chest CT-angiography confirmed a large, 
heterogeneous and highly vascular paracardiac 
mass arising from the pericardium and compressing 
the lateral LV wall and the left inferior pulmonary 
vein without local tissue invasion (Fig. 1A, B). The 
blood supply to the mass originated from a tortuous 
and aneurysmal artery arising from the left main 
coronary artery (LMCA). A contrast-enhanced 
abdomen and pelvis CT scan confirmed the ab-
sence of distant metastases. Coronary angiogram 
showed a voluminous vascular paracardiac mass 
and defined nutrient vessel through large and 
tortuous arteries arising from the LMCA and the 
distal right coronary artery (Fig. 1C, D). Finally, 
18F-fluorodeoxyglucose (FDG) PET-CT (Fig. 1A, E, I) 
scan showed high metabolic activity within the 
paracardiac mass but no hypercaptation of remote 
organs, excluding presence of metastases. Based 
on the integrated multi-modality noninvasive 
cardiac imaging (Fig. 1B, F, J) work-up suggestive 
of an encapsulated, highly vascular, and intraperi-
cardial tumor without surrounding tissue invasion 
or distant metastases, surgical resection of the 
paracardiac mass through a median sternotomy 
was performed. Intraoperative inspection revealed 
a voluminous encapsulated mass, in close contact 
with the left atrial appendage, the coronary arteries 
and the coronary sinus, and without macroscopic 
invasion of the surrounding cardiac structures. The 
tumor was successfully resected albeit requiring 
prolonged cardiopulmonary bypass owing to its 
high bleeding tendency and close anatomic proxim-
ity to the major cardiac structures. The postopera-
Figure 1. Integrated advanced multi-modality noninvasive cardiac imaging demonstrating transaxial (A) and sagittal 
(E) 18F-fluorodeoxyglucose (FDG) myocardial positron emission tomography (PET)-computed tomography (CT) scan 
images of paracardiac mass (black arrows) at the level of pulmonary vessels, and transaxial (I) FDG PET-CT scan im-
age of cardiac mass (black arrow) at the myocardial level. Corresponding images of cardiac mass (white arrows) at 
the same levels are shown for different imaging modalities, including PET-CT scan-cardiac magnetic resonance (CMR) 
fusion (B, F, J), CMR (C, G, K) and contrast-enhanced CT (D, H, L).
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tive course was uneventful and the patient was dis-
charged at day 6. The postoperative TTE showed 
normal LV function with only a localized ex-vacuo 
pericardial effusion at the level of the LV lateral 
wall. Histopathological examination of the tumor 
was consistent with monomorphic cellular prolif-
eration arranged in a Zellballen pattern surrounded 
by richly vascular tissue and sustentacular cells. 
Immunohistochemical stains were positive for neu-
roendocrine differentiation markers (CD56, chro-
mogranin A, synaptophysin) and S-100. Increased 
plasma levels of metanephrine, normetanephrin, 
and 3-methoxytyramine were consistent with 
a functionally active cardiac paraganglioma. Genetic 
analysis demonstrated an heterozygous mutation 
in the succinate dehydrogenase subunit C (SDHC) 
encoding gene, confirming familial paraganglioma.
Cardiac paragangliomas are rare neuroendo-
crine tumors accounting for < 1% of all primary 
cardiac tumors [1]. They are mainly located in the 
pericardium arising from ganglia associated with 
the aorta and the pulmonary or coronary arter-
ies, while only one third originate from intrinsic 
cardiac ganglia located within the atrial walls [4]. 
Malignant paragangliomas occur in only 10% of 
patients owing to presence of distant metastases 
and local tissue invasion [2], but they are associ-
ated with poor clinical outcome due to high recur-
rence rates [3]. Preoperative noninvasive cardiac 
imaging remains therefore essential, but optimal 
preoperative assessment and factors associated 
with adverse surgical and long-term outcomes 
are still unclear, as current evidence is limited to 
retrospective observational series including small 
number of patients. Integration and co-registration 
of advanced cardiac imaging modalities combin-
ing both anatomic (cardiac CT and/or CMR) and 
functional (18FDG PET-CT) information provide 
a unique combination of morphological and metabolic 
tumor characterization. This case highlights the 
incremental value of integrated advanced imaging 
modalities for the diagnosis and the management 
of rare but potentially malignant primary cardiac 
tumors aimed at providing a curative treatment 
stategy key to long-term survival.
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